Regulation

How Will Patient Square's $2.6B Deal Transform Premier?
Business How Will Patient Square's $2.6B Deal Transform Premier?

A Pivotal Moment in Healthcare Investment In an era where the U.S. healthcare industry grapples with escalating costs and the urgent need for innovative solutions, a landmark transaction has emerged to potentially reshape the landscape. Patient Square Capital, a dedicated healthcare investment

Is Dairy M&A Boom a Sign of Sector Strength or Struggle?
Business Is Dairy M&A Boom a Sign of Sector Strength or Struggle?

Today, we’re thrilled to sit down with Faisal Zain, a renowned expert in agricultural economics with a deep focus on the dairy industry. With years of experience analyzing market trends, mergers, and consumer behavior, Faisal has a unique perspective on the recent wave of mergers and acquisitions (

How Will AI Trigger a $1 Trillion Shift in Healthcare?
Technology How Will AI Trigger a $1 Trillion Shift in Healthcare?

In an era where healthcare costs continue to spiral and patient expectations evolve, imagine a system where diseases are predicted before symptoms emerge, treatments are tailored to individual genetic profiles, and care is delivered seamlessly at home through a smartphone. This is not a distant

DexCom Faces FDA Criticism Over Faulty G7 Device Sales
Public Policy DexCom Faces FDA Criticism Over Faulty G7 Device Sales

Overview of the Diabetes Management Technology Industry The diabetes management technology sector stands at a pivotal moment, with continuous glucose monitoring (CGM) devices transforming how millions manage their condition, driven by rapid innovation to provide real-time data to patients and

Malaysia's Health Care Reforms: Bold or Just Repackaged?
Public Policy Malaysia's Health Care Reforms: Bold or Just Repackaged?

Overview of Malaysia's Health Care Landscape Malaysia's health care system operates on a dual structure, blending a robust public sector with a growing private sector, each catering to distinct segments of the population. The public system, managed primarily by the Ministry of Health

FDA Targets Kratom Regulation Amid State Bans and Debate
Public Policy FDA Targets Kratom Regulation Amid State Bans and Debate

Understanding Kratom and Its Current Landscape Kratom, derived from the leaves of the Mitragyna speciosa tree native to Southeast Asia, has emerged as a polarizing substance in the United States, often touted for its potential to alleviate pain and assist in opioid addiction recovery. This

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later